EBiSC

EBiSC

Details

EwC Role: 
Project Partner
Duration: 
1 Jan 2014 - 31 Dec 2017
Client: 
Innovative Medicines Initiative, European Commission (IMI)

ABOUT THIS PROJECT

The goal of European Bank for induced Stem Cells (EBiSC) coordinated by Pfizer Ltd. and managed by Roslin Cells Sciences Ltd. is to establish the supply chain for research-grade human induced pluripotent stem cells (iPSC) with a non-for-profit Biobank in its core.

The Biobank will provide the distribution of disease-relevant quality-controlled iPSC lines, data and services to any qualified user.

Our responsibility is to develop the EBiSC information management system (IMS) and support the business requirement of EBiSC users.

Latest Tweets

Edelweiss Connect (5 weeks ago)
Still time to submit a poster for consideration at the #OpenTox 2022 Virtual Conference The deadline for poster an… https://t.co/XWoGIEpHAn
Edelweiss Connect (2 months ago)
Interested in using a Next Generation #riskassessment Solution? @EdelweissConn plays a leading role in RISK-HUNT3R… https://t.co/XHA2Lr97Bn
Edelweiss Connect (2 months ago)
Join us on August 30 at 16 CEST for the first installment of the #SaferWorldbyDesign: Working days of a cosmetic sa… https://t.co/8yebpqb1Nh
Edelweiss Connect (3 months ago)
We are proud to announce that the catalog of #SaferWorldbyDesign products and services is now available through bot… https://t.co/c6wV90Rh0t
Edelweiss Connect (3 months ago)
SWBD provider SenzaGen obtains OECD approval for GARD®skin #saferskin #skincare #invitro #oecd #machinelearning… https://t.co/OLKn5Jl8Pi

Get in touch

  • Address: Edelweiss Connect GmbH
    Technology Park Basel
    Hochbergerstrasse 60C
    CH-4057 Basel / Basel-Stadt
    Switzerland

USA office

  • Address: Edelweiss Connect Inc
    Research Triangle Park NC
    800 Park Offices Dr
    Durham, NC 27709
    USA